Evidence map›Paper›PMID 35520341›Full record

ArticleRSC advances2020

Terpyridine-based Pd(ii)/Ni(ii) organometallic framework nano-sheets supported on graphene oxide-investigating the fabrication, tuning of catalytic properties and synergetic effects.

Ruirui Ren, Sa Bi, Linhong Wang, Wuduo Zhao, Donghui Wei, Tiesheng Li, Wenjian Xu, Minghua Liu, Yangjie Wu

Abstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruirui RenCollege of Chemistry, Zhengzhou University Zhengzhou 450001 P. R. China.
Sa BiCollege of Chemistry, Zhengzhou University Zhengzhou 450001 P. R. China.
Linhong WangCollege of Chemistry, Zhengzhou University Zhengzhou 450001 P. R. China.ORCID https://orcid.org/0000-0002-4176-3720
Wuduo ZhaoCollege of Chemistry, Zhengzhou University Zhengzhou 450001 P. R. China.ORCID https://orcid.org/0000-0002-9311-9654
Donghui WeiCollege of Chemistry, Zhengzhou University Zhengzhou 450001 P. R. China.
Tiesheng LiCollege of Chemistry, Zhengzhou University Zhengzhou 450001 P. R. China.ORCID https://orcid.org/0000-0002-5214-9574
Wenjian XuCollege of Chemistry, Zhengzhou University Zhengzhou 450001 P. R. China.
Minghua LiuHenan Institute of Advanced Technology, Zhengzhou University Zhengzhou 450001 P. R. China.ORCID https://orcid.org/0000-0002-6603-1251
Yangjie WuCollege of Chemistry, Zhengzhou University Zhengzhou 450001 P. R. China.ORCID https://orcid.org/0000-0002-0134-0870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tailoring the structures of catalysts and the arrangement of organic bimetallic catalysts are essential in both fundamental research and applications. However, they still impose enormous challenges such as size and active species distribution, ordered uniformity, and controllable composition, which are critical in determining their specific activities and efficiency. Herein, a novel terpyridine-based hetero-bimetallic Ni/Pd nanosheet supported on graphene oxide (denoted as GO@Tpy-Ni/Pd) was fabricated, which exhibited higher catalytic activity, substrate applicability and recyclability for the Suzuki coupling reaction under mild conditions. The catalytic mechanism was heterogeneous catalysis at the interface and the synergetic effect between Pd and Ni resulted in a little Ni(0)/Pd(0) cluster including Pd(ii)/Ni(ii) as a whole being formed through electron transfer on the catalytic surface. This phenomenon could be interpreted as the nanoscale clusters of Ni/Pd being the real active centre stabilized by the ligand and GO and the synergetic effect. The absorption and desorption of different substrates and products on Ni/Pd clusters, as calculated by DFT, was proved to be another key factor.

Identifiers

PMID35520341
PMCPMC9054763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.